title: Effect of IVIgG treatment on fetal platelet count, HPA-1a titre and clinical outcome in a case of feto-maternal alloimmune thrombocytopenia.
authors.affiliation: International Blood Group Reference Laboratory, Bristol, UK.
authors.forename: G F
authors.initials: GF
authors.lastname: Lucas
authors.forename: M
authors.initials: M
authors.lastname: Hamon
authors.forename: S
authors.initials: S
authors.lastname: Carroll
authors.forename: P
authors.initials: P
authors.lastname: Soothill
mesh_terms: D016824:Antigens, Human Platelet / Q000032:analysis*; D001327:Autoimmune Diseases / Q000628:therapy*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005331:Fetomaternal Transfusion; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D039661:Integrin beta3; D010976:Platelet Count; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D011256:Pregnancy Outcome; D013921:Thrombocytopenia / Q000097:blood / Q000628:therapy*
chemical_list: D016824:Antigens, Human Platelet; C061248:ITGB3 protein, human; D016756:Immunoglobulins, Intravenous; D039661:Integrin beta3